Skip to content
HowShorted

Akoustis Technologies, Inc. short interest in 2023

In 2023, Akoustis Technologies, Inc.'s disclosed short interest ran from 8.67% of shares outstanding on 13 Jan 2023 to 10.02% on 29 Dec 2023, a change of +1.35 percentage points. The year's high was 10.41% on 30 Nov 2023 and its low 5.60% on 15 Feb 2023, averaging 8.42% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.76 days on 14 Apr 2023. Full history: Akoustis Technologies, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Akoustis Technologies, Inc. in 2023

2023 in figures

Start of year
8.67% (13 Jan 2023)
End of year
10.02% (29 Dec 2023)
Change
+1.35 pp
High
10.41% (30 Nov 2023)
Low
5.60% (15 Feb 2023)
Average
8.42%
Highest days to cover
13.76 (14 Apr 2023)
SEC filings marked
9

Every report in 2023

Akoustis Technologies, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20238.67%13.20
31 Jan 20237.45%3.21results (8-K)
15 Feb 20235.60%3.7910-Q filed, results (8-K)
28 Feb 20236.22%7.69
15 Mar 20236.94%7.77
31 Mar 20237.76%7.24
14 Apr 20237.61%13.76
28 Apr 20237.84%10.72
15 May 20238.06%8.8810-Q filed, results (8-K)
31 May 20237.73%13.11
15 Jun 20237.46%13.36
30 Jun 20237.71%9.48
14 Jul 20237.91%12.06
31 Jul 20237.95%6.73
15 Aug 20239.19%11.12
31 Aug 202310.08%11.53
15 Sep 20239.19%2.4510-K filed, results (8-K)
29 Sep 20238.88%9.21
13 Oct 20239.68%13.37
31 Oct 20239.80%11.81
15 Nov 20239.53%11.0310-Q filed, results (8-K)
30 Nov 202310.41%12.26
15 Dec 202310.37%10.69
29 Dec 202310.02%8.39

See also: Akoustis Technologies, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.